SHANGHAI RIGHTONGENE BIOTECHNOLOGY CO., LTD.

All News Shanghai Rightongene Biotechnology Co., Ltd.

Equities

688217

CNE100005212

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 06/06/2024 BST			5-day change	1st Jan Change
21.65 ^CNY	+1.88%		-9.41%	-39.49%

04-26	Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-29	Shanghai Rightongene Biotechnology Co., Ltd. commences an Equity Buyback Plan for CNY 20 million worth of its shares, under the authorization approved on February 28, 2024.	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Shanghai Rightongene Biotechnology Co., Ltd. commences an Equity Buyback Plan for CNY 20 million worth of its shares, under the authorization approved on February 28, 2024.	02-28	CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02-23	CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
Shanghai Righton Yuntai Biomedical Technology Co., Ltd. announced that it expects to receive CNY 40 million in funding from Shanghai Rightongene Biotechnology Co., Ltd.	05/04/23	CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23	CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22	CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	18/08/22	CI
Shanghai Rightongene Biotechnology Co., Ltd.(SHSE:688217) added to Shanghai Stock Exchange A Share Index	17/05/22	CI
Shanghai Rightongene Biotechnology Co., Ltd.(SHSE:688217) added to Shanghai Stock Exchange Composite Index	17/05/22	CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/04/22	CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/02/22	CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	26/10/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
688217 Stock
News Shanghai Rightongene Biotechnology Co., Ltd.

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW